Pfizer Fined $107 Million by UK Regulator Over Drug Prices
07 December 2016 - 6:50PM
Dow Jones News
By Tapan Panchal
LONDON--The U.K.'s competition regulator has imposed a 84.2
million pound ($107.18 million) fine on pharmaceutical company
Pfizer Inc. (PFE) for charging the country's national health
service excessively high prices for an anti-epilepsy drug.
The Competition and Markets Authority said Wednesday that Pfizer
and drug distribution company Flynn Pharma broke competition law by
charging excessive and unfair prices in the U.K. for phenytoin
sodium capsules, an anti-epilepsy drug.
The regulator fined Flynn Pharma GBP5.2 million and has ordered
both companies to reduce their prices.
-Write to Tapan Panchal at tapan.panchal@wsj.com
(END) Dow Jones Newswires
December 07, 2016 02:35 ET (07:35 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2024 to May 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From May 2023 to May 2024